SCHEMBL22280688

SCHEMBL22280688

COc1ccc2c3ccc(-c4c(C)cc(C)cc4C)cc3n3ccnc3c2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
DYRK1A Q13627 3/20 0.37
MAOA P21397 1/20 0.37
BCHE P06276 1/20 0.37
ACHE P22303 1/20 0.37
KDM4E B2RXH2 4/20 0.36
MAPT P10636 3/20 0.36
HTT P42858 3/20 0.36
SRC P12931 3/20 0.35
LCK P06239 2/20 0.35
KIT P10721 2/20 0.35
GRIK1 P39086 1/20 0.34
GRIK2 Q13002 1/20 0.34
TLR8 Q9NR97 1/20 0.34
LMNA P02545 2/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
L3MBTL1 Q9Y468 3/20 0.34
HPGD P15428 2/20 0.34
HSD17B10 Q99714 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22280909 0.93 BCHE (0.39) ALDH1A1DYRK1AMAOABCHEACHE
SCHEMBL22281107 0.92 DRD1 (0.33) ALDH1A1KDM4ESRCLCKKIT
SCHEMBL22280689 0.87 TNK2 (0.34) ALDH1A1KDM4EMAPTHTTMEN1
SCHEMBL22280691 0.86 TNK2 (0.31) ALDH1A1KDM4ELMNAHPGDTNK2
SCHEMBL22281206 0.85 DRD1 (0.33) ALDH1A1BCHEACHEKDM4ESRC
SCHEMBL22262082 0.84 CDK2 (0.33) ALDH1A1DYRK1AKDM4ETLR8LMNA
SCHEMBL22281108 0.84 PDE4A (0.32) ALDH1A1MEN1KMT2ATNK2
SCHEMBL22280910 0.83 KDM4E (0.34) ALDH1A1KDM4EMAPTHTTLMNA
SCHEMBL22280934 0.82 MET (0.43) ALDH1A1BCHEKDM4EMAPTHTT
SCHEMBL21918412 0.82 ALDH1A1 (0.45) ALDH1A1DYRK1AMAOABCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200239505-A1 BLUE PHOSPHORESCENT EMITTERS EMPLOYING FUNCTIONALIZED IMIDAZOPHENTHRIDINE AND ANALOGUES ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2020-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200239505-A1 BLUE PHOSPHORESCENT EMITTERS EMPLOYING FUNCTIONALIZED IMIDAZOPHENTHRIDINE AND ANALOGUES EML4, TYR, TYMP ALDH1A1 2652/4885DYRK1A 2688/4885MAOA 1878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.